Aurinia Pharmaceuticals Inc (AUPH)

NASDAQ · Biotechnology

15.25
-0.04 (-0.26%)
Updated Aug 18, 5:45 PM ET
AI Rating
Hold
Overall Score
51
Trend
32
Momentum
64
Risk
64

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Aurinia Pharmaceuticals Inc is trading at $15.25, down 0.26% on the session. The 50 day average sits at $15.91 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 49.4, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $15.39 with resistance near $15.77, so that band frames the current range. Average daily movement is roughly $0.59, or about 3.9% of the share price, which is what any stop placement has to allow for. The overall health score of 51 out of 100 combines a trend score of 32, momentum of 64 and a risk score of 64.

Technical indicators

RSI (14)
49.4
neutral
MACD
-0.118
bullish crossover
SMA 20
15.28
SMA 50
15.91
SMA 200
--
unknown
ATR (14)
0.59
avg daily range
Support
15.39
Resistance
15.77
Volume vs 20d
0.72x
below average
Volatility
37.4%
annualised
1 month
-2.95%
3 months
-2.34%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.